等待開盤 10-28 09:30:00 美东时间
-1.261
-2.82%
10月27日,Samsara(IOT)收跌0.6%,报44.65美元,成交额1.73亿美元,市值261.47亿美元。 行情数据 • 开盘价:44.92美元 •...
10-27 04:42
10月20-22日上海黄浦江畔,2026可持续全球领导者大会再度来袭。诺奖、图灵奖得主现场讲述科技未来与趋势,更有“解救”焦虑、内卷时代的网红教授——麦克法兰与...
10-17 04:44
今日重点评级关注:Needham:维持iRhythm Holdings"买入"评级,目标价从192美元升至194美元;HC Wainwright & Co.:维持5E Advanced Materials"买入"评级,目标价从3.5美元升至6.75美元
10-06 16:45
U.S. stocks were mixed, with the Dow Jones index falling over 250 points on Monday. Shares of RXO Inc (NYSE:RXO) rose sharply after C.H. Robinson Worldwide, Inc. (NASDAQ:CHRW) agreed to acquire the company in a cash-and-stock transaction with an implied value of $5.8 billion. Under the deal, RXO sha...
10-05 21:56
Stock index futures were lower on Monday as interest rates remained in focus while Treasury yields seemed to take a breather. Here are four stocks to watch on the day: SpaceX (SPCX) fell 0.34% in pre...
10-05 20:51
Samsara (IOT) was in focus on Monday as Jefferies started coverage on the tech firm with a Buy rating and a $50 price target. Shares were little changed in premarket trading. "IOT serves as a system o...
10-05 19:48
PMV Pharmaceuticals announced the appointment of Dr. Matt Eckler to its Board of Directors. With over two decades of experience in healthcare investing and scientific research, Dr. Eckler will contribute strategic insights as the company prepares to submit an NDA for rezatapopt in 2027. Rezatapopt, a first-in-class p53 reactivator, targets the Y220C mutation in ovarian cancer and has received FDA Fast Track and Orphan Drug Designations. Dr. Eckle...
10-05 12:00
Goldman Sachs says investors should focus on stocks where they see a differentiated view on long-term revenue growth as valuation dispersion remains narrow and growth stocks trade at a sizable premium...
09-27 20:18
Analysts are intrested in these 5 stocks: ( ($ECHO) ), ( ($ENB) ), ( ($RIVN) ),...
09-19 17:01
今日重点评级关注:HC Wainwright & Co.:上调Cardiff Oncology评级至"买入",目标价9美元;古根海姆:维持Inventiva"买入"评级,目标价从11美元升至14美元
09-16 16:10